Concepedia

Hepatic Dose Modification

Hepatic Dose Modification is a clinical pharmacological intervention involving the adjustment of medication dosage based on impaired liver function to maintain therapeutic efficacy and minimize toxicity in patients undergoing oncological treatment.

113

Publications

6.8K

Citations

840

Authors

335

Institutions

Publications per year

2017–2026

26

Parents

Children

Publications

113

Recommendations for Radioembolization of Hepatic Malignancies Using Yttrium-90 Microsphere Brachytherapy: A Consensus Panel Report from the Radioembolization Brachytherapy Oncology Consortium

Andrew S. Kennedy, Subir Nag, Riad Salem et al. · International Journal of Radiation Oncology*Biology*Physics · 2007 · 676 citations

, , +14

Microangiopathy of the brain and retina

John O. Susac, John Hardman, John B. Selhorst · Neurology · 1979 · 386 citations

, , +14

Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy

Massimo Iavarone, Giuseppe Cabibbo, Fabio Piscaglia et al. · Hepatology · 2010 · 352 citations

, , +17

NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: A randomized controlled trial for pharmacogenetics-based therapy

Junichi Azuma, Masako Ohno, Ryuji Kubota et al. · European Journal of Clinical Pharmacology · 2012 · 273 citations · Full text

, , +16

Pegylated Arginine Deiminase Treatment of Patients With Unresectable Hepatocellular Carcinoma: Results From Phase I/II Studies

Francesco Izzo, Paolo Marra, Gerardo Beneduce et al. · Journal of Clinical Oncology · 2004 · 249 citations

, , +17

1–5 of 113

Authors

840

  1. TS
    Theodore S. Lawrence

    University of Michigan, United States

    5 publications · 176 citations

    5

    h-index

  2. RK
    Randall K. Ten Haken

    University of Michigan, United States

    3 publications · 119 citations

    3

    h-index

  3. ME
    Mark Ensor

    University of Kentucky, United States

    2 publications · 267 citations

    2

    h-index

  4. WJ
    Will Jackson

    University of Michigan, United States

    2 publications · 51 citations

    2

    h-index

  5. BS
    Bruno Sangro

    Clinica Universidad de Navarra, Spain

    2 publications · 123 citations

    2

    h-index

1–5 of 840

Institutions

335

  1. University of Michigan

    Ann Arbor, United States

    7 h-index

    40 publications

    1.7K citations

  2. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas

    Madrid, Spain

    3 h-index

    9 publications

    259 citations

  3. The University of Texas MD Anderson Cancer Center

    Houston, United States

    3 h-index

    15 publications

    4K citations

  4. University of Pisa

    Pisa, Italy

    3 h-index

    15 publications

    818 citations

  5. The University of Texas at San Antonio Health Science Center

    San Antonio, United States

    3 h-index

    21 publications

    903 citations

  6. Michigan Medicine

    Ann Arbor, United States

    3 h-index

    6 publications

    276 citations

  7. Inserm

    Paris, France

    3 h-index

    10 publications

    1.3K citations

  8. Case Western Reserve University

    Cleveland, United States

    3 h-index

    27 publications

    1.8K citations

1–8 of 335

Venues

  1. 9

    h-index

  2. PubMed

    Repository · 8 publications · 253 citations

    8

    h-index

  3. Journal of Clinical Oncology

    5 publications · 437 citations

    5

    h-index

  4. Journal of Hepatology

    4 publications · 212 citations

    4

    h-index

  5. Radiology

    3 publications · 301 citations

    3

    h-index

1–5